Cubist Systematic Strategies’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-25,658
Closed -$939K – 2947
2025
Q1
$939K Sell
25,658
-8,150
-24% -$280K 0.01% 1856
2024
Q4
$1.04M Sell
33,808
-60,390
-64% -$2.01M 0.01% 1771
2024
Q3
$3.55M Buy
94,198
+85,047
+929% +$3.28M 0.02% 1061
2024
Q2
$362K Buy
+9,151
New +$296K ﹤0.01% 2276
2024
Q1
– Sell
-13,598
Closed -$453K – 3694
2023
Q4
$453K Buy
+13,598
New +$439K ﹤0.01% 2567
2020
Q4
– Sell
-17,082
Closed -$559K – 2550
2020
Q3
$559K Buy
17,082
+12,585
+280% +$533K 0.01% 1684
2020
Q2
$204K Sell
4,497
-326
-7% -$16.7K ﹤0.01% 2019
2020
Q1
$220K Buy
+4,823
New +$218K 0.01% 1686
2019
Q4
– Sell
-5,683
Closed -$206K – 2406
2019
Q3
$206K Buy
+5,683
New +$240K ﹤0.01% 1757

Other funds holding ATEX

Cubist Systematic Strategies's ATEX Position: Q2 2025 in Review

Cubist Systematic Strategies sold out of Anterix (ATEX) in Q2 2025, closing a stake of 25,658 shares — an estimated $939K sold.

Cubist Systematic Strategies first reported a position in ATEX in Q3 2019 and held it in 9 quarters. The position peaked at $3.55M in Q3 2024. 111 funds tracked by Wall St. Rank hold ATEX as of Q2 2025.

  • Cubist Systematic Strategies reported no remaining Anterix position as of Q2 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 25,658 Anterix shares in Q2 2025, an estimated $939K.
  • Cubist Systematic Strategies first reported a position in Anterix in Q3 2019 and held it in 9 quarters.
  • Cubist Systematic Strategies's Anterix position peaked at $3.55M in Q3 2024.
  • 111 funds tracked by Wall St. Rank held Anterix as of Q2 2025.

Based on Cubist Systematic Strategies's 13F filing for Q2 2025, filed 14 Aug 2025.